Author: digi

FDA Clinical Hold Criteria and Procedures: A Detailed Guide for Regulatory Compliance

May 12, 2025

FDA Clinical Hold Criteria and Procedures: A Detailed Guide for Regulatory Compliance FDA Clinical Hold: Criteria, Procedures, and Sponsor Compliance A clinical hold is an order issued by the U.S. Food and Drug Administration (FDA) that delays or suspends the initiation or continuation of a clinical trial under an Investigational New Drug (IND) application. Understanding…

Regulatory Guidelines, U.S. FDA Regulations

ADME Studies: Understanding Drug Behavior Before Clinical Trials

May 12, 2025

digi

ADME Studies: Understanding Drug Behavior Before Clinical Trials Exploring ADME Studies: How Drugs Behave Before Clinical Trials Begin What Are ADME Studies in Preclinical Research? ADME stands for Absorption, Distribution, Metabolism, and Excretion—a core set of pharmacokinetic processes that describe what the body does to a drug. Understanding these parameters is essential before any new…

Preclinical Studies

Sponsor Responsibilities in Clinical Trials: GCP Compliance and Operational Best Practices

May 12, 2025

digi

Sponsor Responsibilities in Clinical Trials: GCP Compliance and Operational Best Practices Mastering Sponsor Responsibilities for Ethical and Compliant Clinical Trials Sponsors play a pivotal role in the successful execution of clinical trials, bearing primary responsibility for trial initiation, management, financing, monitoring, and regulatory compliance. Their leadership ensures that trials are scientifically sound, ethically conducted, and…

Good Clinical Practice (GCP) and Compliance, Sponsor Responsibilities

Ethics Committee Registration with CDSCO: A Complete Regulatory Guide

May 12, 2025

digi

Ethics Committee Registration with CDSCO: A Complete Regulatory Guide How to Register an Ethics Committee with CDSCO: Step-by-Step Compliance Guide In India, the registration of Ethics Committees (ECs) with the Central Drugs Standard Control Organization (CDSCO) is a mandatory regulatory requirement under the New Drugs and Clinical Trials (NDCT) Rules, 2019. Whether institutional or independent,…

CDSCO (India) Guidelines, Regulatory Guidelines

Regulatory Guidelines for Preclinical Studies (FDA, EMA, CDSCO)

May 11, 2025

digi

Regulatory Guidelines for Preclinical Studies (FDA, EMA, CDSCO) Understanding Preclinical Study Guidelines by FDA, EMA, and CDSCO Why Regulatory Guidelines Matter in Preclinical Studies Before initiating clinical trials in humans, pharmaceutical companies must conduct comprehensive preclinical studies in compliance with international and national regulatory guidelines. These regulations ensure that the data generated is reliable, reproducible,…

Preclinical Studies

EMA Guidance on Good Clinical Practice (GCP): Ensuring Ethical and Compliant Trials in Europe

May 11, 2025

digi

EMA Guidance on Good Clinical Practice (GCP): Ensuring Ethical and Compliant Trials in Europe Understanding EMA’s Good Clinical Practice (GCP) Guidance for Clinical Trials The European Medicines Agency (EMA) plays a crucial role in setting regulatory expectations for clinical trials in Europe, primarily through the adoption and implementation of the International Council for Harmonisation (ICH)…

EMA (European Medicines Agency) Guidelines, Regulatory Guidelines

NDA vs ANDA: Key Regulatory Differences in FDA Drug Approval

May 11, 2025

digi

NDA vs ANDA: Key Regulatory Differences in FDA Drug Approval Understanding the Key Regulatory Differences Between NDA and ANDA The U.S. Food and Drug Administration (USFDA) offers two distinct regulatory pathways for drug approval: the New Drug Application (NDA) and the Abbreviated New Drug Application (ANDA). These routes serve different purposes—one for new and innovative…

Regulatory Guidelines, U.S. FDA Regulations

Role of Animal Models in Predicting Human Outcomes

May 11, 2025

digi

Role of Animal Models in Predicting Human Outcomes How Animal Models Help Predict Drug Outcomes in Humans Introduction: Why Animal Models Are Crucial in Drug Development Animal models serve as indispensable tools in the drug development process. Before a drug ever reaches a human subject, researchers need to understand how it behaves in a complex…

Preclinical Studies

Overview of NDCT Rules, 2019 for Clinical Trials in India

May 11, 2025

digi

Overview of NDCT Rules, 2019 for Clinical Trials in India A Complete Guide to NDCT Rules, 2019 for Clinical Trials in India India’s regulatory landscape for clinical trials underwent a major transformation with the introduction of the New Drugs and Clinical Trials (NDCT) Rules, 2019. Implemented by the Central Drugs Standard Control Organization (CDSCO), these…

CDSCO (India) Guidelines, Regulatory Guidelines

Functional Service Providers (FSPs) in Clinical Trials: Targeted Outsourcing for Flexible Operations

May 11, 2025

digi

Functional Service Providers (FSPs) in Clinical Trials: Targeted Outsourcing for Flexible Operations Essential Strategies for Utilizing Functional Service Providers (FSPs) in Clinical Trials Functional Service Providers (FSPs) offer sponsors a flexible and targeted approach to outsourcing specific clinical trial functions while retaining control over overall study management. By leveraging FSP models, sponsors can scale operations…

Contract Research Organizations (CROs), Functional Service Providers (FSPs)